Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences

CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP
59
Quality control/ assurance procedures are based on extensive BCCA Standard Operating Procedures
compliant with ICH, FDA, and Health Canada Good Clinical Practice (GCP) guidelines. All projects are
approved by the REB prior to initiation and all research staff are trained appropriately in GCP and these
SOPs. The Unit also participates in monitor visits and periodic audits.
Contact:
den Duyf, Johanna. Director, Systemic Therapy and ST Clinical Trials Unit. Tel: 250-519-5591. jdenduyf@
bccancer.bc.ca.
B.C. Children’s Hospital
B.C. Children’s Hospital (BCCH) (www.bcchildrens.ca) is the only pediatric health centre and teaching
hospital in B.C., and the largest full-service child health centre in Western Canada. As B.C.’s tertiary care
facility, it delivers child and youth physical and mental health and rehabilitation services for the most seriously
ill or injured children from across the province. It provides care for more than 72,000 children and
adolescents every year, including 900 children with cancer, 140 undergoing open-heart surgery, 1,200
needing intensive care, and approximately 2,300 children for the assessment of developmental issues
and/or requiring rehabilitation (the latter activities are conducted at BCCH’s Sunny Hill Health Centre for
Children.
Endocrinology and Diabetes Unit
The Endocrinology & Diabetes Unit has an active program for both basic-science and clinical research,
particularly in diabetes and healthy lifestyles (www.bcchildrens.ca/Services/SpecializedPediatrics/EndocrinologyDiabetesUnit/default.htm).
Clinical investigators include the following whose details can be found in Appendix 6:
• Amed, Shazhan • Metzger, Daniel
• Chanoine, Jean-Pierre • Panagiotopoulos, Constadina
Contact:
Chanoine, Jean-Pierre. Head, Division of Pediatric Endocrinology. Tel: 604-875-2624. jchanoine@cw.bc.ca.
General Surgery
The General Surgery Division provides surgical treatment for head and neck, thoracic, digestive, and
oncologic diseases for children of all ages. The division plays an active role in the treatment of birth
defects, traumatic injuries, and vascular access, including extracorporeal membrane oxygenation (www.
bcchildrens.ca/Services/SurgeryAndSurgSuites/GeneralSurgery/default.htm). Clinical research includes
novel fetal therapies, especially those, such as gene replacement, applicable via “minimally invasive”
surgical techniques. The investigators are also interested in outcomes following neonatal surgery. Dr.
Skarsgard is creating a surgical, Canada-wide database that will allow illness-severity stratification of
specific surgical conditions and enable “best practice” assessments for a number of neonatal conditions
requiring surgery after birth (see www.cfri.ca/our_research/researchers/search_researchers/researcher_
detail.aspID=123).
Contact:
Skarsgard, Erik. Head, Division of Pediatric General Surgery. Tel: 604-875-3744. eskarsgard@cw.bc.ca.